The Allstate Co. (NYSE:ALL) CFO Sells $7,480,226.06 in Stock

The Allstate Co. (NYSE:ALL) CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now owns 18,115 shares of the company’s stock, valued at $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Allstate Stock Down 2.7 %

ALL stock opened at $187.53 on Friday. The stock has a market cap of $49.66 billion, a price-to-earnings ratio of 11.04, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52. The company’s 50 day moving average is $191.23 and its 200 day moving average is $189.50. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The Allstate Co. has a 1-year low of $153.87 and a 1-year high of $209.88.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Sell-side analysts predict that The Allstate Co. will post 18.64 EPS for the current fiscal year.

Institutional Trading of Allstate

Several hedge funds and other institutional investors have recently bought and sold shares of ALL. VSM Wealth Advisory LLC purchased a new stake in Allstate in the fourth quarter worth approximately $25,000. FSA Wealth Management LLC purchased a new stake in Allstate in the third quarter worth $26,000. Twin Tree Management LP purchased a new stake in Allstate in the fourth quarter worth $27,000. Northwest Investment Counselors LLC purchased a new stake in Allstate in the third quarter worth $28,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in Allstate in the third quarter worth $29,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ALL shares. Bank of America lifted their target price on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Keefe, Bruyette & Woods lifted their target price on Allstate from $235.00 to $240.00 and gave the company an “outperform” rating in a report on Tuesday. Evercore ISI upgraded Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. The Goldman Sachs Group upped their price target on Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Finally, Piper Sandler upped their price target on Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average price target of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.